FDC Limited — Important, 12-02-2025: Financial Result Updates

FDC Limited has announced a board meeting to discuss its unaudited consolidated financial results for the quarter and nine months ended December 31, 2024.

Consolidated revenue increased by approximately 11% year-over-year to ₹ 1,69,278.32 million (or ₹ 1,692.78 crore), aided by strong demand across its single operating segment, Pharmaceuticals. The growth is likely driven by expanded market presence and fluctuations in supply chain dynamics.

Net profit for the period stood at ₹ 22,811.68 million (or ₹ 228.12 crore), reflecting a notable increase from ₹ 25,894.22 million a year earlier. This translates to Earnings Per Share (EPS) of ₹ 14.02, illustrating robust profitability despite escalating operational costs.

Total expenses were ₹ 1,38,887.40 million (or ₹ 1,388.87 crore), with significant rises in raw material and employee benefits costs. Material costs alone accounted for ₹ 42,460.66 million (or ₹ 424.61 crore), indicating pressures on cost management, while employee expenses reached ₹ 36,076.14 million (or ₹ 360.76 crore).

The balance sheet remains healthy, with adequate cash flow reflecting ongoing operational strength. Looking ahead, FDC’s strategic emphasis on expanding its product portfolio and operational efficiency could position it favorably in a growing industry. Given the promising financial performance and prospects, it would be prudent to consider this stock for potential investment moving forward.